carmustine has been researched along with Lymphoma, T-Cell in 6 studies
Carmustine: A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
carmustine : A member of the class of N-nitrosoureas that is 1,3-bis(2-chloroethyl)urea in which one of the nitrogens is substituted by a nitroso group.
Lymphoma, T-Cell: A group of heterogeneous lymphoid tumors representing malignant transformations of T-lymphocytes.
| Excerpt | Relevance | Reference |
|---|---|---|
| "LDE-carmustine was shown to be safe and effective in a drug combination protocol, which encourages larger studies to investigate the use of this novel formulation to treat canine lymphomas." | 2.80 | Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma. ( Barboza, R; Coelho, BM; Guerra, JL; Lucas, SR; Maranhão, RC; Pozzi, DH, 2015) |
| "We report two patients who developed visual hallucinations during treatment with vincristine." | 1.29 | Visual hallucinations following treatment with vincristine. ( Chapman, CS; Ghosh, K; Murphy, P; Sivakumaran, M; Wood, JK, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lucas, SR | 1 |
| Maranhão, RC | 1 |
| Guerra, JL | 1 |
| Coelho, BM | 1 |
| Barboza, R | 1 |
| Pozzi, DH | 1 |
| Czajczynska, A | 1 |
| Günther, A | 1 |
| Repp, R | 1 |
| Humpe, A | 1 |
| Schub, N | 1 |
| Raff, T | 1 |
| Nickelsen, M | 1 |
| Schrauder, A | 1 |
| Schrappe, M | 1 |
| Kneba, M | 1 |
| Gramatzki, M | 1 |
| Krishnan, GS | 1 |
| Chaudhary, V | 1 |
| Al-Janadi, A | 1 |
| Ramanarayanan, J | 1 |
| D'Silva, KJ | 1 |
| Ghosh, K | 1 |
| Sivakumaran, M | 1 |
| Murphy, P | 1 |
| Chapman, CS | 1 |
| Wood, JK | 1 |
| Tauro, S | 1 |
| Dobie, D | 1 |
| Richardson, G | 1 |
| Hastings, M | 1 |
| Mahendra, P | 1 |
| Goldkuhl, C | 1 |
| Ekman, T | 1 |
| Wiklund, T | 1 |
| Telhaug, R | 1 |
2 trials available for carmustine and Lymphoma, T-Cell
| Article | Year |
|---|---|
Pilot clinical study of carmustine associated with a lipid nanoemulsion in combination with vincristine and prednisone for the treatment of canine lymphoma.
Topics: Animals; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, | 2015 |
Age-adjusted chemotherapy for primary central-nervous system lymphoma--a pilot study.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Central Nervou | 2002 |
4 other studies available for carmustine and Lymphoma, T-Cell
| Article | Year |
|---|---|
Allogeneic stem cell transplantation with BEAM and alemtuzumab conditioning immediately after remission induction has curative potential in advanced T-cell non-Hodgkin's lymphoma.
Topics: Adult; Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Pr | 2013 |
BCNU toxicity presenting with a large pericardial and pleural effusion.
Topics: Adult; Androstadienes; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Proto | 2008 |
Visual hallucinations following treatment with vincristine.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Cyclophosphamide; Doxorubicin | 1994 |
Recurrent penicillin-resistant pneumococcal sepsis after matched unrelated donor (MUD) transplantation for refractory T cell lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bone Marrow Transplantation; Carm | 2000 |